
| Pair Name | Oleanolic Acid, Gemcitabine | ||
| Phytochemical Name | Oleanolic Acid (PubChem CID: 10494 ) | ||
| Anticancer drug Name | Gemcitabine (PubChem CID: 60750 ) | ||
| Structure of Phytochemical |
Download
2D
MOL
3D
MOL
|
||
| Structure of Anticancer Drug |
Download
2D
MOL
3D
MOL
|
||
| Pair Name | Oleanolic Acid, Gemcitabine | |||
| Disease Info | [ICD-11: 2C10.Z] | Pancreatic cancer | Investigative | |
| Biological Phenomena | Induction-->Mitochondrial damage | |||
| Gene Regulation | Down-regulation | Expression | SPINK1 | hsa6690 |
| Down-regulation | Expression | EGFR | hsa1956 | |
| Down-regulation | Expression | MAPK1 | hsa5594 | |
| Down-regulation | Expression | MAP2K7 | hsa5609 | |
| Down-regulation | Expression | EZH2 | hsa2146 | |
| In Vitro Model | AsPC-1 | Pancreatic ductal adenocarcinoma | Homo sapiens (Human) | CVCL_0152 |
| MIA PaCa-2 | Pancreatic ductal adenocarcinoma | Homo sapiens (Human) | CVCL_0428 | |
| Result | We found an interesting finding that the 73-03 in combination with GCB can improve GCB efficacy and decrease PCa resistance, which induced apoptosis and mitochondrial damage through epigenetic inhibition of SPINK1 transcription by miR-421 up-regulation. This was the first study that used OA derivatives on GCB-resistant PCa cells, so this combined strategy warrants further investigation. | |||
| No. | Title | Href |
|---|---|---|
| 1 | Enhancement of gemcitabine efficacy by K73-03 via epigenetically regulation of miR-421/SPINK1 in gemcitabine resistant pancreatic cancer cells. Phytomedicine. 2021 Oct;91:153711. doi: 10.1016/j.phymed.2021.153711. | Click |